WHY START WITH ANORO?

Over half of patients had moderate or worse lung function at COPD diagnosis1*

The dual bronchodilation of ANORO could help your patients from the start2

View head-to-head lung function efficacy data for ANORO, a LAMA/LABA:

ANORO was studied in patients with moderate or worse COPD.3,4

*In a subset (n=366) of a managed-care-population with a coded diagnosis of COPD severity based on GOLD stages 2 to 4.1

Consider Starting with ANORO for your symptomatic
patients with COPD

Explore data for ANORO ELLIPTA vs. a LAMA alone

ANORO vs SPIRIVA

Explore head-to-head data for a LAMA/LABA vs a LAMA alone

COMPARE TO SPIRIVA

Explore data for ANORO ELLIPTA vs. an ICS/LABA

ANORO vs ADVAIR

See head-to-head data for a LAMA/LABA vs an ICS/LABA

COMPARE TO ADVAIR

Icon of walking person and a checklist

Health-Related Quality-of-Life Data

What daily, health-related, quality-of-life improvements can ANORO make for your patients?

VIEW THE DATA